Dr. Stewart R Grote , DO
Internal Medicine • Lansing, KS
712 1st Ter
Lansing, KS 660431704
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Stewart Grote is listed in NPPES under Internal Medicine.
-
NPI assigned on August 16, 2005; this date does not establish years in practice.
-
Published CMS data list 597 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Gabapentin — 43 prescription fills, including refills.
- Carvedilol — 36 prescription fills, including refills.
- Levothyroxine Sodium — 33 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 31 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Internal Medicine in Kansas (2024, 563 clinicians with data). Median for this group: 681. Middle half: 69 to 6,121.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 482 in 2020 to 597 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
712 1st Ter
Lansing, KS 660431704
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
981 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$54,531 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $490.38 across 27 records.
By nature of payment
- Food and Beverage: $490.38 across 27 records.
Reporting-company totals (3 largest of 9)
- Novartis Pharmaceuticals Corporation: $158.81 across 14 records.
- Bristol Myers Squibb Company: $105.50 across 1 record.
- Viatris Specialty LLC: $45.94 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Grote has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Grote as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Lansing and Kansas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Internal Medicine in Kansas (2024, 563 clinicians with data). Median for this group: 681. Middle half: 69 to 6,121.
Too few clinicians listed under Internal Medicine in Lansing have Medicare Part D data for 2024 to compare.
Part D drug cost
Close to the middle for clinicians listed under Internal Medicine in Kansas (2024, 563 clinicians with data). Median for this group: $64,741. Middle half: $1,924 to $449,985.
Too few clinicians listed under Internal Medicine in Lansing have Medicare Part D data for 2024 to compare.
3 active clinicians are listed under Internal Medicine with a practice address in Lansing, KS (1,018 in Kansas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 24% from 482 in 2020 to 597 in 2024.
- 2020: 482
- 2021: 556
- 2022: 701
- 2023: 633
- 2024: 597
-
30-day fills
30-day fills increased 39% from 707 in 2020 to 981 in 2024.
- 2020: 707
- 2021: 971
- 2022: 1,206
- 2023: 1,116
- 2024: 981
-
Part D drug cost
Part D drug cost decreased 38% from $87,382 in 2020 to $54,531 in 2024.
- 2020: $87,382
- 2021: $74,781
- 2022: $75,900
- 2023: $59,776
- 2024: $54,531
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $902.72 in 2021 to $490.38 in 2025.
- 2021: $902.72
- 2022: $604.03
- 2023: $268.12
- 2024: $656.26
- 2025: $490.38
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 27 records totaling $490.38.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $105.50 |
| Alkermes, Inc. |
Food and Beverage
In-kind items and services
|
VIVITROL | General | $30.91 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $25.73 |
| Philips North America LLC |
Food and Beverage
Cash or cash equivalent
|
Vest Therapy Und | General | $23.07 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $22.11 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $20.51 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $20.21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $19.83 |
| Electromed, Inc. |
Food and Beverage
Cash or cash equivalent
|
SMARTVEST | General | $18.44 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $18.43 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
HETLIOZ | General | $17.53 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $16.88 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $16.82 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $16.63 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $16.24 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $16.04 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
HETLIOZ | General | $14.69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $14.08 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
ENTRESTO | General | $13.35 |
| Electromed, Inc. |
Food and Beverage
Cash or cash equivalent
|
SMARTVEST | General | $13.24 |
| Electromed, Inc. |
Food and Beverage
Cash or cash equivalent
|
SMARTVEST | General | $12.30 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $4.03 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $3.09 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $3.06 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $2.88 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Gabapentin | Gabapentin | 43 | 2,104 | $1,600.93 | 13 |
| Carvedilol | Carvedilol | 36 | 2,250 | $206.04 | 11 |
| Levothyroxine Sodium | Levothyroxine Sodium | 33 | 1,830 | $86.50 | — |
| Tamsulosin Hcl | Tamsulosin Hcl | 32 | 1,680 | $342.37 | — |
| Tizanidine Hcl | Tizanidine Hcl | 31 | 923 | $466.35 | — |
| Prednisone | Prednisone | 28 | 910 | $195.51 | — |
| Atorvastatin Calcium | Atorvastatin Calcium | 22 | 1,800 | $88.27 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 22 | 1,500 | $82.27 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | 660 | $310.55 | — |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 22 | 1,410 | $102.38 | — |
| Trazodone Hcl | Trazodone Hcl | 20 | 600 | $108.62 | — |
| Mounjaro | Tirzepatide | 20 | 588 | $21,854.47 | — |
| Amlodipine Besylate | Amlodipine Besylate | 19 | 1,170 | $66.61 | — |
| Furosemide | Furosemide | 19 | 1,050 | $73.22 | — |
| Buspirone Hcl | Buspirone Hcl | 19 | 560 | $61.20 | — |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | 870 | $98.19 | — |
| Celecoxib | Celecoxib | 18 | 1,320 | $826.23 | — |
| Metoprolol Succinate | Metoprolol Succinate | 15 | 870 | $87.38 | — |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 630 | $830.83 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 176 | $208.23 | 12 |
| Kerendia | Finerenone | 14 | 420 | $8,953.72 | — |
| Lisinopril | Lisinopril | 12 | 1,080 | $166.53 | — |
| Losartan Potassium | Losartan Potassium | 12 | 900 | $82.10 | — |
| Ozempic | Semaglutide | 12 | 336 | $11,219.56 | — |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | 290 | $94.69 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSORDER AND REFERRING ONLY - INTERNAL MEDICINE
I20150716000878
KS
5799675583
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Registered Nurse Practitioner
Physician Assistant
Physician Assistant (Certified)
Otolaryngology
Doctor of Osteopathic Medicine (D.O.)
Family Medicine
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated August 16, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Lansing
Mailing Address
712 1st Ter
Lansing, KS 660431704
Phone: 9137276000